Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126390801 | 12639080 | 1 | I | 20160726 | 20160809 | 20160809 | EXP | US-JNJFOC-20160724006 | JOHNSON AND JOHNSON | KOCH DG, TILLMAN H, DURKALSKI V, LEE WM, REUBEN A. DEVELOPMENT OF A MODEL TO PREDICT TRANSPLANT-FREE SURVIVAL OF PATIENTS WITH ACUTE LIVER FAILURE. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2016;14 (8):1199-1206. | 0.00 | Y | 0.00000 | 20160809 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126390801 | 12639080 | 1 | PS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | N | 19872 | UNKNOWN | |||||||||
| 126390801 | 12639080 | 2 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | N | 19872 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126390801 | 12639080 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126390801 | 12639080 | HO |
| 126390801 | 12639080 | LT |
| 126390801 | 12639080 | DE |
| 126390801 | 12639080 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126390801 | 12639080 | Acute hepatic failure | |
| 126390801 | 12639080 | Overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |